In the open letter released on September 8, the nine leading firms of the pharmaceutical industry declared their determination to “unite to stand with science.” The FDA guidelines were the gold standard of drug regulation, and they would follow these to the letter.33 It was a further instance of the refusal of big business to fall into line with Trump’s agenda, and this one had immediate practical consequences.
